Specialized care for all breast cancer subtypes including hormone receptor-positive, HER2-positive, and triple-negative breast cancer with personalized treatment approaches.
Expert care for all breast cancer subtypes with molecular profiling, personalized hormone therapy, HER2-targeted treatments, and immunotherapy for triple-negative breast cancer. We focus on breast-conserving approaches and comprehensive survivorship care.
Digital breast tomosynthesis (DBT) for enhanced detection, especially in dense breast tissue. Annual screening recommended from age 40.
Comprehensive testing for ER, PR, HER2, Ki-67, and genomic assays (Oncotype DX, MammaPrint) for treatment decisions.
BRCA1/BRCA2 and other hereditary breast cancer gene testing for high-risk patients and family members.
Painless lump or thickening in the breast or underarm that persists through the menstrual cycle.
Skin dimpling, redness, scaliness, or peau d’orange; nipple inversion or discharge (clear/bloody).
Breast pain, warmth, or swelling not linked to injury or common cyclical changes.
BRCA1/2 mutations, strong family history, prior chest radiation increase risk.
Early menarche, late menopause, first childbirth after 30, long-term HRT.
Obesity, alcohol use, sedentary lifestyle; limited physical activity.
Comprehensive monitoring and surveillance for long-term health and well-being.
Connecting patients with support groups and counseling services.
Managing side effects and improving overall quality of life post-treatment.